Ann: Coronavirus and manufacturing update, page-113

Boom. Go Jat!

Appendix 4C Highlights
• Record monthly revenue of $8.5 million achieved in February and $8.1 million in March, driven by increased lactoferrin sales due to emergence of the COVID-19 pandemic

• A fourth successive cash flow positive quarter, with $18.5 million in cash receipts generating $1.65 million in net cash from operations

• ANMA operations continue to expand, boosting production through double shifts and recruitment of new staff, with first stage of construction and installation of new machinery at ANMA facility completed and additional equipment ordered to meet demand for new products

• JAT forms research partnership with University of Sydney to develop antiviral food supplement

• First order of dairy products under $80 million Ocker agreement secured and first batch of plant-based meat products ready for shipping by mid-May under JV

• Cash balance of $10.5 million as at 31 March 2020, after which JAT secured $5 million in new funding for capital expenditure and working capital